The global sex reassignment treatment market is anticipated to grow at a CAGR of around 10.8% during the forecast period (2021-2027). The growing public awareness and research about the symptoms and behavior traits of a person suffering from gender dysphoria is the major factor boosting the growth of the sex reassignment treatment market.
As per the Cedars-Sinai research report published in June 2020, the mean age of transgender women to experience symptoms of gender dysphoria is 4.5-6.7 years, while the mean age of transgender men to experience the same symptoms is 4.7-6.2 years. A transgender woman lives around 27 years and a transgender man lives around 23 years of social life before adopting sex reassignment treatment. Such researches enable the market players to identify their targeted audiences.
Browse the full report description of "Global Sex Reassignment Treatment Market Size, Share & Trends Analysis Report by Gender Transition (Male to Female and Female to Male) Forecast Period (2021-2027)" at https://www.omrglobal.com/industry-reports/sex-reassignment-treatment-market
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
o By Gender Transition
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape-includes Boston Medical Center, Carl Zeiss AG, Fielmann AG, Johnson & Johnson Services, Inc., Safilo Group S.p.A., Adidas AG, Luxottica Group S.p.A., Warby Parker.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Sex Reassignment Treatment Market Report Segment
By Gender Transition
• Male to Female
• Female to Male
Global Sex Reassignment Treatment Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/sex-reassignment-treatment-market